| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Invitae Corp | Chief Financial Officer | Common Stock | 242K | $157K | $0.65 | Jun 14, 2021 | Direct |
| NGM BIOPHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 0 | Apr 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NGM | NGM BIOPHARMACEUTICALS INC | Apr 5, 2024 | 5 | $0 | 4 | Apr 8, 2024 | Director |
| NGM | NGM BIOPHARMACEUTICALS INC | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Director |
| NGM | NGM BIOPHARMACEUTICALS INC | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
| NVTA | Invitae Corp | Jun 14, 2021 | 1 | -$313K | 4 | Jun 16, 2021 | Chief Financial Officer |
| NGM | NGM BIOPHARMACEUTICALS INC | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
| NVTA | Invitae Corp | May 6, 2021 | 2 | -$94.1K | 4 | May 20, 2021 | Chief Financial Officer |